This company listing is no longer active
ORCD Stock Overview
Orchid Ventures, Inc. engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Orchid Ventures, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.09 |
| 52 Week Low | CA$0.01 |
| Beta | 1.4 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -72.22% |
| 3 Year Change | -75.00% |
| 5 Year Change | n/a |
| Change since IPO | -98.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| ORCD | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -3.6% | -2.1% |
| 1Y | -72.2% | 58.0% | 3.6% |
Return vs Industry: ORCD underperformed the Canadian Pharmaceuticals industry which returned -63.6% over the past year.
Return vs Market: ORCD underperformed the Canadian Market which returned -3.7% over the past year.
Price Volatility
| ORCD volatility | |
|---|---|
| ORCD Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 14.2% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: ORCD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ORCD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Corey Mangold | www.orchidessentials.com |
Orchid Ventures, Inc. engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America. It provides cannabis vapor devices, such as kits and cartridges. The company offers its products through approximately 150 dispensaries across California and Oregon.
Orchid Ventures, Inc. Fundamentals Summary
| ORCD fundamental statistics | |
|---|---|
| Market cap | CA$1.32m |
| Earnings (TTM) | -CA$4.20m |
| Revenue (TTM) | CA$1.78m |
0.7x
P/S Ratio-0.3x
P/E RatioIs ORCD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORCD income statement (TTM) | |
|---|---|
| Revenue | US$1.33m |
| Cost of Revenue | US$1.31m |
| Gross Profit | US$24.20k |
| Other Expenses | US$3.18m |
| Earnings | -US$3.16m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 1.81% |
| Net Profit Margin | -236.45% |
| Debt/Equity Ratio | 0% |
How did ORCD perform over the long term?
See historical performance and comparison